Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer (Q46601882)
Jump to navigation
Jump to search
scientific article published on 12 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer |
scientific article published on 12 July 2005 |
Statements
1 reference
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer (English)
1 reference
M Karthaus
1 reference
Harald Ballo
1 reference
Wolgang Abenhardt
1 reference
Tilmann Steinmetz
1 reference
Thomas Geer
1 reference
Jorg Schimke
1 reference
Dietrich Braumann
1 reference
Rudiger Behrens
1 reference
Dirk Behringer
1 reference
Manfred Kindler
1 reference
Helmut Messmann
1 reference
Hans-Peter Boeck
1 reference
Roland Greinwald
1 reference
Ulrich Kleeberg
1 reference
12 July 2005
1 reference
1 reference
68
1 reference
4-6
1 reference
326-332
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference